“North America is expected to hold the highest share in 2020”

North America commanded the largest share of the therapeutic drug monitoring market in 2019.

North America commanded the largest share of the therapeutic drug monitoring market in 2019.

In 2020, F. Hoffmann-La Roche established its presence in Cape Town, South Africa to increase their research, development and biotech production capabilities. The site will be built, featuring laboratory, biotech production and office workspace.

North America commanded the largest share of the therapeutic drug monitoring market in 2019.

“North America is expected to hold the highest share in Therapeutic Drug Monitoring Market 2020”

Antiepileptic drugs segment is expected to hold the largest share of the market in 2020

Consumables segment is expected to hold the largest share of the market in 2020

The demand for therapeutic drug monitoring is anticipated to witness considerable growth from hospital laboratories in 2019

Antiepileptic drugs segment is expected to hold the largest share of the market in 2020

OPPORTUNITY: Increasing adoption in the treatment of autoimmune diseases

North America commanded the largest share of the therapeutic drug monitoring market.

North America is expected to hold the highest share in 2020

Growth Driver: importance of TDM in organ transplant procedures

Asia Pacific is expected to grow at the highest CAGR during the forecast period

Asia Pacific is expected to grow at the highest CAGR during the forecast period

Asia Pacific is expected to grow at the highest CAGR during the forecast period

Therapeutic Drug Monitoring Market by Product (Consumable, Equipment (Immunoassay analyzer)), Technology (Fluorescence Immunoassay, Radioimmunoassay, GCMS), Class of drugs (Antibiotics, Bronchodilators), End User (Hospital Lab) - Global Forecast to 2023

Asia Pacific is expected to grow at the highest CAGR during the forecast period

Asia Pacific is expected to grow at the highest CAGR during the forecast period

The growth of this market is majorly driven by the rising number of organ transplant procedures and the use of TDM in traditional anticancer therapies.

The Global Therapeutic Drug Monitoring Market is projected to reach USD 1.63 billion in 2023 from USD 1.23 billion in 2018, at a CAGR of 5.9%

The Global Therapeutic Drug Monitoring Market is projected to reach USD 1.63 billion in 2023 from USD 1.23 billion in 2018, at a CAGR of 5.9%

The therapeutic drug monitoring market is projected to reach to reach USD 1.63 billion by 2023 from USD 1.16 billion in 2017 at a CAGR of 5.9% during the forecast period.

The global therapeutic drug monitoring market is projected to reach USD 1.63 billion in 2023 from USD 1.23 billion in 2018, at a CAGR of 5.9%.

Therapeutic Drug Monitoring Market by Product (Consumables, Equipment), Technology (Immunoassays, Proteomic Technologies), Class of Drug (Antiepileptics, Antibiotics, Immunosuppressants), End User (Hospital Labs, Private Labs) - Global Forecast to 2020

Therapeutic Drug Monitoring Market by Product (Consumables, Equipment), Technology (Immunoassays, Proteomic Technologies), Class of Drug (Antiepileptics, Antibiotics, Immunosuppressants), End User (Hospital Labs, Private Labs) - Global Forecast to 2020

The report "Therapeutic Drug Monitoring Market by Product (Consumables, Equipment), Technology (Immunoassays, Proteomic Technologies), Class of Drug (Antiepileptics, Antibiotics, Immunosuppressants), End User (Hospital Labs, Private Labs) - Global Forecas